Inflammatory fibroblasts in cancer

被引:32
作者
Lim, Hyesol [1 ]
Moon, Aree [1 ]
机构
[1] Duksung Womens Univ, Coll Pharm, Duksung Innovat Drug Ctr, Seoul 132714, South Korea
关键词
Fibroblasts; Cancer-associated fibroblasts (CAFs); Tumor microenvironment; Epithelial-mesenchymal transition (EMT); EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED FIBROBLASTS; INVASIVE DUCTAL CARCINOMA; FACTOR-KAPPA-B; ACTIVATION PROTEIN; HUMAN BREAST; IN-VITRO; STROMAL FIBROBLASTS; CELL-SURFACE; MATRIX METALLOPROTEINASES;
D O I
10.1007/s12272-016-0787-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The association between inflammation and cancer has been studied widely. Indeed, the tumor microenvironment is influenced by inflammatory cells and affects tumor progression, tumor growth, and the survival of cancer cells. Also, the tumor microenvironment is essential to invasion and metastasis of cancer. Fibroblasts, immune cells, the extracellular matrix and other various components all constitute the tumor stroma, ordinarily referred to as the 'reactive stroma'. Cancer-associated fibroblasts (CAFs), which are activated fibroblasts and one of the components of the tumor microenvironment, are associated with cancer progression, invasiveness and metastasis, and their functional contributions to these processes are beginning to emerge. CAFs mediate tumor-promoting inflammation through various signaling pathways. Epithelial-mesenchymal transition is a process for producing mesenchymal cells during invasion and metastasis of cancer cells. Fibroblasts have been identified as a key player in this mechanism. In the present review, we summarize the relationships between fibroblasts, inflammatory response, the tumor microenvironment and cancer progression. This review provides useful information for the development of cancer prevention and treatment therapies through controlling the inflammatory responses.
引用
收藏
页码:1021 / 1031
页数:11
相关论文
共 149 条
[1]   Pathways connecting inflammation and cancer [J].
Allavena, Paola ;
Garlanda, Cecilia ;
Borrello, Maria Grazia ;
Sica, Antonio ;
Mantovani, Alberto .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :3-10
[2]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[3]  
Ames Bruce N., 1995, Microbiologia (Madrid), V11, P305
[4]  
Ariga N, 2001, INT J CANCER, V95, P67, DOI 10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO
[5]  
2-U
[6]   Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer? [J].
Assenat, E ;
Gerbal-Chaloin, S ;
Maurel, P ;
Vilarem, MJ ;
Pascussi, JM .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (06) :785-792
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   The tumor microenvironment at a glance [J].
Balkwill, Frances R. ;
Capasso, Melania ;
Hagemann, Thorsten .
JOURNAL OF CELL SCIENCE, 2012, 125 (23) :5591-5596
[9]   A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS [J].
BASSET, P ;
BELLOCQ, JP ;
WOLF, C ;
STOLL, I ;
HUTIN, P ;
LIMACHER, JM ;
PODHAJCER, OL ;
CHENARD, MP ;
RIO, MC ;
CHAMBON, P .
NATURE, 1990, 348 (6303) :699-704
[10]   A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer [J].
Bauman, Julie E. ;
Eaton, Keith D. ;
Wallace, Sarah G. ;
Carr, Laurie L. ;
Lee, Sang-Joon ;
Jones, Dennie V. ;
Arias-Pulido, Hugo ;
Cerilli, Lisa A. ;
Martins, Renato G. .
BMC CANCER, 2012, 12